Key result
Sporadic facioscapulohumeral muscular dystrophy is hypothesized to involve de novo variants linked to more severe phenotypes.
Why the study?
The systematic clinical characteristics and natural history of sporadic FSHD cases with de novo pathogenic variants remain poorly defined.
Observational analysis explores phenotypic severity in sporadic facioscapulohumeral muscular dystrophy, highlighting the clinical impact of de novo pathogenic variants.
Background and Objectives: Facioscapulohumeral muscular dystrophy (FSHD) includes approximately 10%-30% sporadic cases, where de novo pathogenic variants are hypothesized to be associated with more severe phenotypes. However, the systematic clinical characteristics and natural history of these cases remain poorly defined. Methods: This retrospective observational cohort study was conducted at the Fujian Neuromedical Center, enrolling patients with genetically confirmed FSHD who were classified as de novo (dnFSHD) when no pathogenic D4Z4 contraction was detected in blood samples from either available parent. Clinical and genetic parameters at baseline and during subsequent evaluations were compared between dnFSHD and familial FSHD (fFSHD). The fFSHD cohort was matched for sex and disease duration. Mediation analysis was applied to explore the relationships among de novo pathogenic variants, the number of D4Z4 repeats, and disease progression. Results: = 0.021). Mediation analysis indicated that D4Z4 RUs mediated 72% of the correlation between dnFSHD and lower extremity involvement and 48% of the association with age-corrected clinical severity scale. Discussion: This study establishes dnFSHD as a distinct, high-risk FSHD subtype characterized by unique clinical features, with its severe phenotype primarily mediated by a shorter D4Z4 repeat array.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question. Sporadic facioscapulohumeral muscular dystrophy cases, comprising 10% to 30% of the disease, are hypothesized to involve de novo pathogenic variants associated with more severe phenotypes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: